No Prescription |
 |
 | ||
|
Zofran Generic Ondansetron |
|
| ||
No Prescription » Prescription Drugs 17 » Zofran Generic Ondansetron Ondansetron injection is used to prevent nausea and vomiting caused by cancer chemotherapy and surgery. Ondansetron is in a class of medications called 5-HT3 receptor antagonists. It works by blocking the action of serotonin a natural substance that may cause nausea and vomiting.Ondansetron comes as a solution (liquid) to be injected intravenously (into a vein) or into a muscle by a health care provider in a hospital or clinic. When ondansetron is used to prevent nausea and vomiting caused by chemotherapy it is usually given 30 minutes before the start of chemotherapy. Additional doses may be given 4 hours after the first dose and 8 hours after the first dose. When ondansetron is used to prevent nausea and vomiting caused by surgery it is usually given just before the surgery. Ondansetron is also sometimes given after surgery to patients who are experiencing nausea and vomiting and did not receive ondansetron before surgery. Buy Zofran Generic Ondansetron and other Prescription Drugs 17 products online at Medstore. Buy Online at Medstore - Click Here!
About Zofran Generic Ondansetron: Product Type: Prescription Drugs 17 Zofran ( Generic Ondansetron ) Zofran (Generic Ondansetron) Generic Ondansetron 4mg/2ml Generic Ondansetron Zofran
View more Prescription Drugs 17 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
